HRP20130076T1 - Formulacije tobramicina za lijeäśenje endobronhijalnih infekcija - Google Patents
Formulacije tobramicina za lijeäśenje endobronhijalnih infekcija Download PDFInfo
- Publication number
- HRP20130076T1 HRP20130076T1 HRP20130076TT HRP20130076T HRP20130076T1 HR P20130076 T1 HRP20130076 T1 HR P20130076T1 HR P20130076T T HRP20130076T T HR P20130076TT HR P20130076 T HRP20130076 T HR P20130076T HR P20130076 T1 HRP20130076 T1 HR P20130076T1
- Authority
- HR
- Croatia
- Prior art keywords
- dry powder
- aerosol composition
- use according
- powder aerosol
- tobramycin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58084804P | 2004-06-18 | 2004-06-18 | |
| PCT/US2005/021952 WO2006002178A1 (en) | 2004-06-18 | 2005-06-20 | Methods of treatment of endobronchial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130076T1 true HRP20130076T1 (hr) | 2013-03-31 |
Family
ID=35782127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130076TT HRP20130076T1 (hr) | 2004-06-18 | 2005-06-20 | Formulacije tobramicina za lijeäśenje endobronhijalnih infekcija |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20080214481A1 (enExample) |
| EP (1) | EP1765288B1 (enExample) |
| JP (3) | JP2008503500A (enExample) |
| KR (2) | KR20120131245A (enExample) |
| CN (1) | CN101014320B (enExample) |
| AU (1) | AU2005258078B2 (enExample) |
| BR (1) | BRPI0512146A (enExample) |
| CA (1) | CA2570976C (enExample) |
| DK (1) | DK1765288T3 (enExample) |
| EC (1) | ECSP077182A (enExample) |
| ES (1) | ES2399279T3 (enExample) |
| HR (1) | HRP20130076T1 (enExample) |
| IL (1) | IL179873A (enExample) |
| MA (1) | MA28740B1 (enExample) |
| MX (1) | MXPA06014567A (enExample) |
| NO (1) | NO338799B1 (enExample) |
| NZ (1) | NZ552047A (enExample) |
| PL (1) | PL1765288T3 (enExample) |
| PT (1) | PT1765288E (enExample) |
| RU (1) | RU2389477C2 (enExample) |
| SG (1) | SG153833A1 (enExample) |
| SI (1) | SI1765288T1 (enExample) |
| TN (1) | TNSN06420A1 (enExample) |
| WO (1) | WO2006002178A1 (enExample) |
| ZA (1) | ZA200700420B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI324518B (en) * | 2001-12-19 | 2010-05-11 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
| USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
| US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
| US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
| US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
| US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
| US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
| US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
| US20100093650A1 (en) * | 2006-10-11 | 2010-04-15 | Laboratories Smb S.A. | Pharmaceutical Anit-Infective Composition for Inhalation |
| EP1938822A1 (en) * | 2006-12-21 | 2008-07-02 | Novartis AG | Combination therapy for the treatment of airways disease |
| US8834930B2 (en) | 2008-05-15 | 2014-09-16 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| PT2435025T (pt) * | 2009-05-29 | 2016-11-11 | Pearl Therapeutics Inc | Administração, por via respiratória, de agentes activos |
| JP5795584B2 (ja) | 2009-08-31 | 2015-10-14 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 医療用装置 |
| CA2784207C (en) * | 2009-12-14 | 2018-06-05 | Chiesi Farmaceutici S.P.A. | Antibiotic microparticles for inhalation |
| EP4434458A3 (en) | 2010-03-24 | 2024-12-18 | Abbott Diabetes Care, Inc. | Medical device inserters |
| US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
| US9572774B2 (en) | 2011-05-19 | 2017-02-21 | Savara Inc. | Dry powder vancomycin compositions and associated methods |
| US8603439B2 (en) | 2011-07-12 | 2013-12-10 | Cardeas Pharma Inc. | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| US8826904B2 (en) | 2011-07-12 | 2014-09-09 | Cardeas Pharma Corporation | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| DK3831283T3 (da) | 2011-12-11 | 2023-05-30 | Abbott Diabetes Care Inc | Analytsensorindretninger, forbindelser og fremgangsmåder |
| WO2014055456A1 (en) * | 2012-10-07 | 2014-04-10 | Abbott Diabetes Care Inc. | Medical device insertion indicators |
| CN102949379B (zh) * | 2012-11-14 | 2014-11-05 | 中山大学 | 硫酸奈替米星吸入粉雾剂及其制备方法 |
| JP6454323B2 (ja) | 2013-03-15 | 2019-01-16 | パール セラピューティクス，インコーポレイテッド | 粒子状結晶性材料のコンディショニングのための方法及びシステム |
| EP3294134B1 (en) | 2015-05-14 | 2020-07-08 | Abbott Diabetes Care Inc. | Inserter system for a compact medical device and corresponding method |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| EP3570735A4 (en) | 2017-01-23 | 2020-10-21 | Abbott Diabetes Care Inc. | SYSTEMS, DEVICES AND METHODS FOR INSERTING ANALYTE SENSOR |
| MX2021007294A (es) | 2018-12-21 | 2021-07-15 | Abbott Diabetes Care Inc | Sistemas, dispositivos y metodos para la insercion de sensores de analito. |
| WO2020163416A1 (en) * | 2019-02-05 | 2020-08-13 | Mylan Inc | Devices and methods for tobramycin inhalation treatment |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| MY192294A (en) | 2020-08-31 | 2022-08-17 | Abbott Diabetes Care Inc | Systems, devices, and methods for analyte sensor insertion |
| EP4413917B1 (en) | 2020-09-15 | 2025-12-03 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte monitoring |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
| EP4370029A1 (en) | 2021-07-16 | 2024-05-22 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte monitoring |
| US12702332B2 (en) | 2022-01-04 | 2026-08-11 | Abbott Diabetes Care Inc. | Systems, devices, and methods for analyte monitoring |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| FR2224175B1 (enExample) | 1973-04-04 | 1978-04-14 | Isf Spa | |
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
| SE438261B (sv) | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
| GB8314308D0 (en) | 1983-05-24 | 1983-06-29 | Matburn Holdings Ltd | Medical administration devices |
| SU1335297A1 (ru) * | 1984-06-15 | 1987-09-07 | Донецкий медицинский институт им.М.Горького | Способ лечени больных хроническими заболевани ми легких |
| US4805811A (en) | 1985-03-29 | 1989-02-21 | Aktiebolaget Draco | Dosage device |
| SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| GB8909891D0 (en) | 1989-04-28 | 1989-06-14 | Riker Laboratories Inc | Device |
| IT1243344B (it) | 1990-07-16 | 1994-06-10 | Promo Pack Sa | Inalatore plurimonodose per medicamenti in polvere |
| ES2141108T3 (es) | 1991-07-02 | 2000-03-16 | Inhale Inc | Metodo y dispositivo para proporcionar medicamentos en aerosol. |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
| US5388572A (en) | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same |
| AU696387B2 (en) | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
| ATE387925T1 (de) | 1994-09-21 | 2008-03-15 | Nektar Therapeutics | Vorrichtung und verfahren zum dispergieren von trockenen pulvermedikamenten |
| US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
| US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
| AU706195B2 (en) | 1995-04-14 | 1999-06-10 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
| US5826633A (en) | 1996-04-26 | 1998-10-27 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
| CA2332369A1 (en) * | 1998-05-27 | 1999-12-02 | Euroceltique S.A. | Drug delivery system comprising a tightly compacted solid medicament stock |
| CN1348377A (zh) * | 1998-12-17 | 2002-05-08 | 希龙公司 | 用气溶胶化的抗生素治疗严重慢性支气管炎(支气管扩张症)的方法 |
| CA2382821A1 (en) | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| ES2261735T3 (es) | 2001-05-18 | 2006-11-16 | Chiron Corporation | Sistema para la administracion de una formulacion de tobramicina. |
| DE10131917A1 (de) | 2001-07-02 | 2003-01-23 | Infineon Technologies Ag | Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat |
| MXPA04004631A (es) | 2001-11-14 | 2004-08-12 | Nektar Therapeutics Al Corp | Aparato en aerosol que comprende cuerpo conectable y pieza de extremo. |
| US20030094173A1 (en) | 2001-11-14 | 2003-05-22 | Inhale Therapeutic Systems, Inc. | Aerosolization device with improved endpiece connection |
| TWI324518B (en) * | 2001-12-19 | 2010-05-11 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| JP4739672B2 (ja) | 2001-12-21 | 2011-08-03 | ネクター セラピューティクス | 湿気のバリアを有するカプセルパッケージ |
| EP1501479A1 (en) | 2002-05-07 | 2005-02-02 | Nektar Therapeutics | Capsules for dry powder inhalers and methods of making and using same |
| CN1493297A (zh) * | 2003-09-13 | 2004-05-05 | 南昌弘益科技有限公司 | 妥布霉素吸入粉雾剂及其制备方法 |
-
2005
- 2005-06-20 DK DK05766064.9T patent/DK1765288T3/da active
- 2005-06-20 WO PCT/US2005/021952 patent/WO2006002178A1/en not_active Ceased
- 2005-06-20 HR HRP20130076TT patent/HRP20130076T1/hr unknown
- 2005-06-20 PT PT57660649T patent/PT1765288E/pt unknown
- 2005-06-20 NZ NZ552047A patent/NZ552047A/xx not_active IP Right Cessation
- 2005-06-20 RU RU2007101906/14A patent/RU2389477C2/ru active
- 2005-06-20 KR KR1020127029971A patent/KR20120131245A/ko not_active Ceased
- 2005-06-20 KR KR1020067026608A patent/KR20070026604A/ko not_active Ceased
- 2005-06-20 SG SG200904155-9A patent/SG153833A1/en unknown
- 2005-06-20 EP EP05766064A patent/EP1765288B1/en not_active Expired - Lifetime
- 2005-06-20 AU AU2005258078A patent/AU2005258078B2/en not_active Expired
- 2005-06-20 MX MXPA06014567A patent/MXPA06014567A/es active IP Right Grant
- 2005-06-20 US US11/570,584 patent/US20080214481A1/en not_active Abandoned
- 2005-06-20 BR BRPI0512146-9A patent/BRPI0512146A/pt not_active Application Discontinuation
- 2005-06-20 CA CA2570976A patent/CA2570976C/en not_active Expired - Lifetime
- 2005-06-20 ES ES05766064T patent/ES2399279T3/es not_active Expired - Lifetime
- 2005-06-20 JP JP2007516838A patent/JP2008503500A/ja active Pending
- 2005-06-20 PL PL05766064T patent/PL1765288T3/pl unknown
- 2005-06-20 CN CN2005800201762A patent/CN101014320B/zh not_active Expired - Lifetime
- 2005-06-20 SI SI200531661T patent/SI1765288T1/sl unknown
-
2006
- 2006-12-06 IL IL179873A patent/IL179873A/en active IP Right Grant
- 2006-12-18 TN TNP2006000420A patent/TNSN06420A1/en unknown
-
2007
- 2007-01-15 ZA ZA200700420A patent/ZA200700420B/xx unknown
- 2007-01-15 NO NO20070253A patent/NO338799B1/no unknown
- 2007-01-17 MA MA29618A patent/MA28740B1/fr unknown
- 2007-01-18 EC EC2007007182A patent/ECSP077182A/es unknown
-
2011
- 2011-01-04 US US12/984,110 patent/US20110097412A1/en not_active Abandoned
-
2012
- 2012-02-22 JP JP2012036405A patent/JP2012107047A/ja active Pending
- 2012-02-24 US US13/404,359 patent/US8664187B2/en not_active Expired - Fee Related
- 2012-12-27 JP JP2012284937A patent/JP2013056947A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012107047A5 (enExample) | ||
| JP2004534763A5 (enExample) | ||
| JP2008503500A5 (enExample) | ||
| BR9914384A (pt) | Dispositivo e método para liberação de um agente ativo em aerossol aos pulmões de um paciente humano | |
| JP2004532859A5 (enExample) | ||
| MXPA06014567A (es) | Metodo para el tratamiento de infecciones endobronquiales. | |
| AR022930A2 (es) | MICROCAPSULAS, DE TIPO RESERVORIO, QUE CONTIENEN POR LO MENOS UN PRINCIPIO ACTIVO MEDICAMENTOSO Y/O NUTRITIVO (PA) CON EXCLUSION DEL ACIDO ACETILSALICILICO (ASA), DESTINADAS A LA ADMINISTRACION POR VIA ORAL, SU UTILIZACIoN Y FORMA FARMACEUTICA QUE COMPRENDE A DICHAS MICROCAPSULAS. | |
| SI1991201T1 (en) | NEBULISED ANTIBIOTICS FOR INHALATION THERAPY | |
| KR20130130689A (ko) | 에어로졸화에 의한 토브라마이신의 투여에 의한 폐 감염의 치료 | |
| DE60210402D1 (de) | System zur Abgabe einer Tobramycin-Formulierung | |
| BR0303348A (pt) | Formulações de aerossol para administração pulmonar de medicamentos com o intuito de produzir efeito sistêmico | |
| WO2008013929A3 (en) | Anti-migraine oral spray formulations and methods | |
| BR0015676A (pt) | Composição pesticida, método para controlar pestes, e, uso de uma composição de gel aerado estável em armazenamento | |
| BR0210630A (pt) | Sistema fornecedor de liberação prolongada | |
| EP3463325B1 (en) | Microparticles comprising a sulphur-containing compound | |
| BR0115524A (pt) | Pó seco dispersìvel para transferência pulmonar e método de tratamento de um estado de doença responsivo ao tratamento por meio de um agente terapêutico | |
| BR0112330A (pt) | Formulações de macrolìdeos para inalação e seus usos para o tratamento de infecções endobrÈnquicas | |
| CA2316018A1 (en) | Novel pharmaceutical compositions of uridine triphosphate | |
| ES8600930A1 (es) | Un metodo para producir un preparado granular que contiene procimidona, facilmente dispersable en agua | |
| AU2011304259A1 (en) | Antimicrobial and wound-healing action pharmaceutical composition for external application process of producing the same | |
| Debnath et al. | Status of inhalable antimicrobial agents for lung infection: progress and prospects | |
| EP4408435B1 (en) | Composition comprising hesperidin, citral and sodium alginate as a film-forming substance for prophylaxis of infections | |
| Makhoul et al. | Antibiotic Treatment of Experimental Pseudomonas aerugi nosa Pneumonia in Guinea Pigs: Comparison of Aerosol and Systemic Administration | |
| ES2957220T3 (es) | Preparación farmacéutica y su uso en el tratamiento de laringitis vírica | |
| AU752266B2 (en) | Micronised pharmaceutical compositions |